IGBMC - Institut de génétique et de biologie moléculaire et cellulaire

Type : Rapports des entités de recherche

Campagne d'évaluation : 2022-2023 (vague C) - Publié le : 17/05/2023

Établissement(s) concerné(s) : Université de Strasbourg , Centre national de la recherche scientifique - CNRS , Institut national de la santé et de la recherche médicale - INSERM

Domaine(s) disciplinaire(s) de recherche : Sciences de la vie et de la terre (SVE) ; SVE3 - Molécules du vivant, biologie intégrative (des gènes et génomes aux systèmes), biologie cellulaire et du développement pour la science animale

Panel(s) ERC : LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction ; LS2 Genetics, Genomics, Bioinformatics and Systems Biology: genetics, population genetics, molecular genetics, genomics, transcriptomics, proteomics, metabolomics, bioinformatics, computational biology, biostatistics, biological modelling and simulation,

Nom des équipes de l'unité : Team 1: Structural biology of epigenetic targets ; Team 2: Chemical biophysics of transcriptional signalling ; Team 3: Biomolecular condensation in nuclear organisation and function ; Team 4: Biomolecular Nuclear Magnetic Resonance ; Team 5: Large complexes involved in gene expression ; Team 6: Chromatin stability and DNA mobility ; Team 7: Molecular Basis of Chromatin and Transcription Regulation ; Team 8: Structural biology of molecular machines ; Team 9: Transcription co-activators ; Team 10: Viral Oncoproteins and Domain-motif networks ; Team 11: Regulation of transcription ; Team 12: Molecular Basis for Protein Synthesis by the Ribosome ; Team 43: Biophysics of cell growth and division ; Team 13: Brain development and physiology ; Team 14: Differentiation and physiopathology of endocrine cells in the pancreas and intestine ; Team 15: In vivo cellular plasticity and direct reprogramming ; Team 16: Common Mechanisms of Development, Cancer and Aging ; Team 17: Nuclear organisation and division ; Team 18: Stochastic Systems Biology of Gene Regulation ; Team 19: Molecular biology of B cells ; Team 20: Actin dynamics and biomechanics of the early embryo ; Team 21: Signal transduction in metabolism and inflammation ; Team 22: Cell physics ; Team 23: Cell cycle and ubiquitin signalling ; Team 24: Dynamics of chromatin structure and transcription regulation ; Team 25: Structural and functional basis of chromatin remodelling ; Team 26: Hematopoiesis and Disease ; Team 27: Genome expression and repair ; Team 28: Regulation of gene expression in cancer ; Team 29: Pathophysiology of vitamin A signalling pathways ; Team 30: Transcriptional regulation of neural and immune development ; Team 31: Chromatin and epigenetic regulation ; Team 32: Pathogenesis of inflammatory diseases ; Team 33: Pathophysiological role of nuclear receptor signalling ; Team 34: Eukaryotic mRNA decay ; Team 35: Spatial organisation of the genome ; Team 36: Molecular and cellular biology of breast cancer ; Team 37: RNA Diseases ; Team 38: Regulation of cortical development and disease ; Team 39: Study of copy number variants in autism spectrum disorders and their comorbidities ; Team 40: Pathophysiology of Down's syndrome and rare dose-effect diseases causing intellectual disabilities (ID) or autism spectrum disorders (ASD) and other comorbidities ; Team 41: Pathophysiology of neuromuscular diseases Name of the supervisor: Ms. Jocelyn Laporte ; Team 42: Genetics and pathophysiology of neurodevelopmental Disorders

Mot(s) clé(s) : Regulation of gene expression ; Cell fate decisions